Skip to content

Genetic Susceptibility Factors for Candidemia.

Genetic Susceptibility Factors Involved in Candidemia: Case-control Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02841501
Enrollment
453
Registered
2016-07-22
Start date
2013-06-30
Completion date
2020-06-25
Last updated
2021-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidemia, Genetic Predisposition to Disease, Invasive Candidiasis

Keywords

Gene Expression Profiling, Genome-Wide Association Study, Polymorphism, Single Nucleotide, Drug Resistance, Fungal

Brief summary

This is a prospective case-control physiopathological study, which main objective is to determine the genetic host factors predisposing to candidemia. Secondary objectives are to develop new diagnosis tools using the biological collection, to describe and update epidemiology, to analyse the influence of genetic polymorphisms on prognosis.

Interventions

An analysis of the SNPs (single nucleotide polymorphism) of 25 candidate genes will be performed. This analysis will be completed by a genome wide association study.

Sponsors

Seventh Framework Programme
CollaboratorOTHER
University of Lausanne Hospitals
CollaboratorOTHER
University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient older than 18 years. * Informed consent. * Positive blood culture with isolation of Candida sp.

Exclusion criteria

* No informed consent. * Patient younger than 18. * No insurance coverage.

Design outcomes

Primary

MeasureTime frame
Frequency of the polymorphisms between the groupsIn the 48-72 hours following the positive blood culture

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026